Prostate Cancer - Results from #80

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. March 15, 2023

Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer. March 15, 2023

Spatial patterns of prostate-specific antigen testing in asymptomatic men across Australia: a population-based cohort study, 2017-2018. March 15, 2023

Mass Spectrometry-Based Assessment of Prostate Cancer-Associated Crystalloids Reveals Enrichment for Growth & Differentiation Factor 15 (GDF15). March 14, 2023

Upfront Androgen Receptor-Axis-Targeted Therapies in Men with De Novo High-Volume Metastatic Hormone-Sensitive Prostate Cancer. March 14, 2023

PSMA-positive circulating tumor cell detection and outcomes with abiraterone or enzalutamide treatment in men with metastatic castrate resistant prostate cancer. March 14, 2023

Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. March 14, 2023

The Impact of Within-Consultation and Pre-Consultation Decision Aids for Localized Prostate Cancer on Patient Knowledge: Results of a Patient-Level Randomized Trial. March 14, 2023

Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study. March 14, 2023

Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. March 13, 2023

Efficacy of urine loss ratio for prognosis of urinary continence after radical prostatectomy: A retrospective cohort study in a single Japanese institution. March 13, 2023

Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study. March 13, 2023

A Randomised Feasibility Trial of Stereotactic Prostate Radiotherapy with or without Elective Nodal Irradiation in High-Risk Localised Prostate Cancer (SPORT Trial). March 13, 2023

Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy: Retrospective multicenter study with different MRI scanners. March 13, 2023

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study. March 13, 2023

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer March 12, 2023

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer March 12, 2023

A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer. March 12, 2023

The Hunt for Lymph Nodes: Is Total Submission of Standard and Extended-Template Pelvic Lymph Node Dissections Necessary for Detecting Metastatic Prostate Cancer? March 10, 2023

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy. March 10, 2023

Page 5 of 1290